Large order from Danish biotec company Glycom

DSS, part of Tetra Pak Filtration Solutions, has won the order for the filtration part of a large production facility for HMO in Esbjerg Denmark. The order comprises several membrane filtration plants, including ceramic UF plant and spiral-wound NF plants. 

HMOs are small fibers, which are found in human milk. They create and maintain a strong gut barrier defence and healthy intestinal microbiotia in infants and adults, and they are the biggest difference between infant formula and mother’s milk.  As a result, HMOs have the potential to address a number of global health challenges. HMOs are unique, wonderful, gentle, natural compounds that offer many health benefits.  Glycom can now manufacture them in large quantities and offer them to the world for the first time.

Glycom a privately held company, founded in 2005 and based in Denmark. The company is focussed on the development, synthesis and commercialization of human milk oligosaccharides (HMOs).